pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
actym-therapeutics PRESS RELEASE ARCHIVE
Nov 7, 2022
Actym Therapeutics Reports Preclinical Data Demonstrating ACTM-838's Ability to Generate Anti-Tumor Immunity
May 12, 2022
Actym Therapeutics Announces Significant Expansion of Senior Leadership
Feb 28, 2022
Actym Therapeutics and Wacker Biotech Sign Manufacturing Contract for Actym's Lead Candidate for the Treatment of Solid Tumors
Feb 16, 2022
Actym Therapeutics CEO Dr. Christopher Thanos named one of the "Top 25 Biotech CEOs of 2022"
Feb 14, 2022
Actym Therapeutics Announces Issuance of US Patent
Nov 12, 2021
Actym Therapeutics Announces Lead Candidate for Clinical Development, Presentation at SITC
Nov 11, 2021
Actym Therapeutics Appoints Chan Whiting as Chief Development Officer
Jan 13, 2021
Actym Therapeutics Announces Expansion of Scientific Advisory Board
Apr 27, 2020
Actym Therapeutics Raises $34 Million Series A
Nov 8, 2019
Actym Therapeutics Will Present Data at the 2019 Society for the Immunotherapy of Cancer (SITC) Annual Meeting
Apr 2, 2019
Actym Therapeutics Will Present Data at the 2019 American Association for Cancer Research Annual Meeting
Nov 8, 2018
Actym Therapeutics Will Present Data at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
